Do State Cost Control Policies Reduce Medicaid Prescription Drug Spending?

dc.contributor.author	Tennyson, Sharon
dc.date.accessioned	2010-06-11T13:45:18Z
dc.date.available	2010-06-11T13:45:18Z
dc.date.issued	2009
dc.description.abstract	We present the first systematic analysis of state policies limiting prescription drug access under Medicaid during 1990–2004, documenting their impact on states’Medicaid prescription spending growth.We see substantial variation in the number and type of policies used by states, but a clear upward trend in restrictions over time. Analysis of state level annual spending growth shows that these restrictions have in general helped contain Medicaid prescription drug costs and that some approaches, such as the use of preferred drug lists (PDLs) and tiered copayment systems, may have been more effective than others.	en_US
dc.identifier.citation	Risk Management and Insurance Review Vol. 12 No. 1 Winter 2009: 37-64	en_US
dc.identifier.uri	https://hdl.handle.net/1813/15116
dc.language.iso	en_US	en_US
dc.subject	Policy Analysis and Management	en_US
dc.title	Do State Cost Control Policies Reduce Medicaid Prescription Drug Spending?	en_US
dc.type	article	en_US

Files

Now showing 1 - 1 of 1